ERYTECH Pharma (ERYP) Short Interest Ratio & Short Volume → Central Bank Gold Heist In Progress (From Colonial Metals) (Ad) Free ERYP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media ERYTECH Pharma Short Interest DataCurrent Short Volume17,800 sharesPrevious Short Volume37,900 sharesChange Vs. Previous Month-53.03%Dollar Volume Sold Short$14,606.68Short Interest Ratio / Days to Cover0.1Last Record DateJune 15, 2023Outstanding Shares34,120,000 sharesPercentage of Shares Shorted0.05%Today's Trading Volume0 sharesAverage Trading Volume93,510 sharesToday's Volume Vs. Average0% Short Selling ERYTECH Pharma ? Sign up to receive the latest short interest report for ERYTECH Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatERYP Short Interest Over TimeERYP Days to Cover Over TimeERYP Percentage of Float Shorted Over Time Ad Colonial MetalsCentral Bank Gold Heist In ProgressWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ERYTECH Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202317,800 shares $14,606.68 -53.0%N/A0.1 $0.82 5/31/202337,900 shares $35,622.21 -60.1%N/A0.3 $0.94 5/15/202395,000 shares $107,350.00 +138.7%N/A0.7 $1.13 4/30/202339,800 shares $34,307.60 +15.0%N/A0.3 $0.86 4/15/202334,600 shares $33,382.08 +2.1%N/A1.2 $0.96 3/31/202333,900 shares $33,222.00 -11.0%N/A1 $0.98 Get the Latest News and Ratings for ERYP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter. 3/15/202338,100 shares $27,569.16 -0.8%N/A0.8 $0.72 2/28/202338,400 shares $32,670.72 -5.4%N/A0.8 $0.85 2/15/202340,600 shares $35,768.60 +12.8%N/A0.8 $0.88 1/31/202336,000 shares $32,403.60 -47.7%N/A0.7 $0.90 1/15/202368,800 shares $34,056.00 +45.2%N/A1.8 $0.50 12/30/202247,400 shares $15,646.74 +9.7%N/A1.5 $0.33 12/15/202243,200 shares $21,600.04 -5.7%N/A1.4 $0.50 11/30/202245,800 shares $27,484.58 No ChangeN/A3 $0.60 11/15/202245,800 shares $29,770.00 -18.8%N/A3 $0.65 10/31/202256,400 shares $35,537.64 +46.1%N/A4 $0.63 10/15/202238,600 shares $27,108.78 -26.3%N/A3.1 $0.70 9/30/202252,400 shares $28,814.76 -12.2%N/A4.2 $0.55 9/15/202259,700 shares $47,760.00 -16.9%N/A4.9 $0.80 8/31/202271,800 shares $66,450.90 +17.5%N/A5.7 $0.93 8/15/202261,100 shares $78,208.00 +5.9%N/A4.7 $1.28 7/31/202257,700 shares $61,162.00 -6.8%N/A2.4 $1.06 7/15/202261,900 shares $64,376.00 -6.6%N/A0.1 $1.04 6/30/202266,300 shares $74,256.00 -9.8%N/A0.1 $1.12 6/15/202273,500 shares $77,175.00 -9.5%N/A0.1 $1.05 5/31/202281,200 shares $94,192.00 -15.9%N/A0.1 $1.16 5/15/202296,500 shares $105,185.00 -84.4%N/A0.1 $1.09 4/30/2022618,700 shares $829,058.00 +105.8%N/A0.7 $1.34 4/15/2022300,600 shares $357,714.00 +118.9%N/A0.4 $1.19 3/31/2022137,300 shares $240,275.00 -3.1%N/A1.3 $1.75 3/15/2022141,700 shares $253,728.02 -17.2%N/A3.7 $1.79 2/28/2022171,200 shares $303,024.00 -3.4%N/A4.4 $1.77 2/15/2022177,300 shares $333,324.00 +0.5%N/A1.5 $1.88 1/31/2022176,500 shares $338,880.00 +1.9%N/A1.4 $1.92 1/15/2022173,300 shares $400,323.00 -5.6%N/A1 $2.31 12/31/2021183,500 shares $431,225.00 -11.1%N/A1.1 $2.35 12/15/2021206,400 shares $474,720.00 +1,395.7%N/A1.2 $2.30 11/30/202113,800 shares $37,536.00 +62.4%0.1%0.1 $2.72 11/15/20218,500 shares $21,250.00 -57.1%0.0%0.1 $2.50 10/29/202119,800 shares $57,420.00 -66.3%0.1%0.2 $2.90My next big prediction isn’t a prediction (Ad)I believe this could change your life forever. I’m talking about transforming everything for you, financially. You see, a rare market anomaly has emerged that I believe is going to make some people very wealthy. Almost nobody in the mainstream media or Wall Street has connected the dots on what’s going on, but that ignorance won’t last for long. When they wake up to this situation, billions of dollars will flood in.Click here now to sign up ERYP Short Interest - Frequently Asked Questions What is ERYTECH Pharma's current short interest? Short interest is the volume of ERYTECH Pharma shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 17,800 shares of ERYP short. Learn More on ERYTECH Pharma's current short interest. Is ERYTECH Pharma's short interest increasing or decreasing? ERYTECH Pharma saw a drop in short interest in the month of June. As of June 15th, there was short interest totaling 17,800 shares, a drop of 53.0% from the previous total of 37,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ERYTECH Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ERYTECH Pharma: Protalix BioTherapeutics, Inc. (7.70%), Cardiol Therapeutics Inc. (0.58%), Athira Pharma, Inc. (2.22%), aTyr Pharma, Inc. (0.18%), Outlook Therapeutics, Inc. (7.89%), BioAtla, Inc. (10.66%), AlloVir, Inc. (5.16%), Genenta Science S.p.A. (0.02%), Instil Bio, Inc. (0.33%), Passage Bio, Inc. (1.51%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.80 billion), Canadian Natural Resources Limited ($3.69 billion), Charter Communications, Inc. ($2.95 billion), Occidental Petroleum Co. ($2.78 billion), Moderna, Inc. ($2.38 billion), Palantir Technologies Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.19 billion), Coinbase Global, Inc. ($2.08 billion), Royal Caribbean Cruises Ltd. ($2.02 billion), and Verisk Analytics, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short ERYTECH Pharma stock? Short selling ERYP is an investing strategy that aims to generate trading profit from ERYTECH Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ERYTECH Pharma? A short squeeze for ERYTECH Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ERYP, which in turn drives the price of the stock up even further. How often is ERYTECH Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERYP, twice per month. The most recent reporting period available is June, 15 2023. More Short Interest Resources from MarketBeat Related Companies: PLX Short Interest Data CRDL Short Interest Data ATHA Short Interest Data LIFE Short Interest Data OTLK Short Interest Data BCAB Short Interest Data ALVR Short Interest Data GNTA Short Interest Data TIL Short Interest Data PASG Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ERYP) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetryThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy